Two Sigma Investments’s NRX Pharmaceuticals NRXP Stock Holding History

Two Sigma Investments’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$108K	Buy	+26,429	New	+$87.3K	﹤0.01%	4878
2026 Q1	–	Sell	-17,436	Closed	-$47.3K	–	4816
2025 Q4	$47.3K	Sell	17,436 -34,896	-67%	-$93.7K	﹤0.01%	3943
2025 Q3	$173K	Buy	52,332 +20,880	+66%	+$59.8K	﹤0.01%	3399
2025 Q2	$103K	Buy	31,452 +1,306	+4%	+$3.27K	﹤0.01%	2994
2025 Q1	$61.8K	Buy	+30,146	New	+$84.9K	﹤0.01%	3026
2022 Q3	–	Sell	-4,145	Closed	-$25K	–	2703
2022 Q2	$25K	Buy	+4,145	New	+$54.4K	﹤0.01%	2389

Other funds holding NRXP

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Investments's NRXP Position: Q2 2026 in Review

Two Sigma Investments opened a new position in NRX Pharmaceuticals (NRXP) in Q2 2026: 26,429 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #4878 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in NRXP as recently as Q4 2025.

Two Sigma Investments first reported a position in NRXP in Q2 2022 and has held it in 6 quarters since. The position peaked at $173K in Q3 2025. 46 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

Two Sigma Investments held 26,429 shares of NRX Pharmaceuticals worth $108K as of Q2 2026.
NRX Pharmaceuticals was a new Two Sigma Investments position in Q2 2026.
NRX Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q2 2026, its #4878 holding.
Two Sigma Investments first reported a position in NRX Pharmaceuticals in Q2 2022 and has held it in 6 quarters since.
Two Sigma Investments's NRX Pharmaceuticals position peaked at $173K in Q3 2025.
46 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.